A strategy for managing recombinant human Factor VIIa (NovoSeven®) off-label use in the academic hospital setting

被引：0
|
作者：
Harris, SB [1 ]
Lögdberg, LE [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
TRANSFUSION | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159A / 159A
页数：1
相关论文
共 50 条
  • [41] Adjunct use of NovoSeven (recombinant factor VIIa) for penetrating cardiac trauma
    Manuel Garcia-Nunez, Luis
    Enrique Soto-Ortega, Luis
    Cabello-Pasini, Ruy
    Enrique Payro-Hernandez, Luis
    Javier Magana-Sanchez, Ignacio
    CIRUGIA Y CIRUJANOS, 2008, 76 (01): : 95 - 98
  • [42] Off-Label Use of Recombinant Activated Factor VII -- Safe or Not Safe?.
    Aledort, Louis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1853 - 1854
  • [43] The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulant
    Billon, S
    Le Niger, C
    Escoffre-Barbe, M
    Vicariot, M
    Abgrall, JF
    BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (07) : 551 - 553
  • [44] Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery
    Chapman, Alistair J.
    Blount, Andrew L.
    Davis, Alan T.
    Hooker, Robert L.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (06) : 1314 - 1319
  • [45] Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis
    Gokcebay, Dilek Gurlek
    Fettah, Ali
    Kirbas, Ismail
    Tunc, Bahattin
    Ozbek, Namik Yasar
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (01) : 73 - 76
  • [46] Off-label use of recombinant activated factor VII (rFVIIa) in children.
    Punzalan, RC
    Ghanayem, NS
    Gill, JC
    Jaquiss, RDB
    Montgomery, RR
    Gottschall, JL
    BLOOD, 2003, 102 (11) : 137B - 137B
  • [47] Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding
    Flynn, Brigid C.
    Steiner, Marie E.
    Mazzeffi, Michael
    ANESTHESIOLOGY, 2023, 139 (02) : 197 - 210
  • [48] OFF-LABEL USE OF ACTIVATED RECOMBINANT FACTOR VII. A SPANISH THREE LEVEL HOSPITAL'S EXPERIENCE
    Perez-Montes, R.
    Gonzalez-Mesones, B.
    Ruiz, M.
    Uresandi, A.
    Nunez, J.
    Sedano, C.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 396 - 396
  • [49] Off-label use of tocilizumab in a tertiary hospital
    Anderssen Nordahl, Emilie
    Bosch Ferrer, Montserrat
    Hortala Bas, Cristina
    Agusti Escasany, Antonia
    Alerany Pardo, Carme
    Villar Casares, Maria
    Danes Carreras, Immaculada
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 17 - 17
  • [50] American experience with home use of NovoSeven(R): Recombinant factor VIIa in hemophiliacs with inhibitors
    Shapiro, AD
    HAEMOSTASIS, 1996, 26 : 143 - 149
12345